These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7303757)

  • 21. [Comparative studies on the effect of delayed therapy of chronic inflammatory liver diseases with prednisone or immunosuppressive agents].
    Evers C; Vorpahl WD; Weinreich J
    Med Welt; 1971 Mar; 12():465-8. PubMed ID: 5560083
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term results of immunosuppressive treatment of chronic aggressive hepatitis (author's transl)].
    Gottesmann T; Moeschlin S
    Dtsch Med Wochenschr; 1978 Dec; 103(50):1989-93. PubMed ID: 720235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Data of prognostic value in the study of chronic hepatitis. Results obtained with immunosuppressive agents].
    Aguilar Reina J; De la Santa J; Andreu Kern F
    Rev Esp Enferm Apar Dig; 1973 Oct; 41(3):243-54. PubMed ID: 4755603
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
    Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
    Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to steroid and immunosuppressor therapy in patients with chronic active liver disease (CALD) non-related to the presence of hepatitis Bs antigen.
    Robles G; Centeno F; Uribe M; Guevara L
    Rev Invest Clin; 1980; 32(3):271-6. PubMed ID: 7444226
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone.
    Mackay IR
    Q J Med; 1968 Jul; 37(147):379-92. PubMed ID: 4175634
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis.
    Husby G; Blomhoff JP; Skrede S; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(7):621-9. PubMed ID: 4588517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppressive therapy of chronic hepatitis].
    Meyer zum Büschenfelde
    Dtsch Med J; 1969 Aug; 20(16):522-7. PubMed ID: 5344061
    [No Abstract]   [Full Text] [Related]  

  • 32. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies].
    Carotti A
    Minerva Med; 1980 Nov; 71(47):3429-34. PubMed ID: 7454095
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of chronic hepatitis].
    Dioguardi N
    Minerva Med; 1974 Nov; 65(82):4261-6. PubMed ID: 4431580
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prognosis of chronic hepatitis].
    Terg R; Kogan Z; Abecasis R; Lorente S; Melazzini F; Podestá A
    Acta Gastroenterol Latinoam; 1980; 10(1):35-48. PubMed ID: 7435127
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating thyroxine in chronic active liver disease.
    Barzilai DC; Soloway RD; Summerskill WH; Schoenfield LJ
    Isr J Med Sci; 1974 Nov; 10(11):1405-14. PubMed ID: 4443216
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive treatment of chronic hepatitis in the light of observed cases].
    Stempień R; Bergiel A; Fabianowski J
    Pol Tyg Lek; 1974 Aug; 29(37):1583-6. PubMed ID: 4409789
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prolonged treatment with prednisone and azathioprine in chronic hepatitis with immunological disorders].
    Runcan V; Oproiu A; State I; Vlădăreanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(4):273-7. PubMed ID: 777
    [No Abstract]   [Full Text] [Related]  

  • 38. [Azathioprine in active chronic hepatitis].
    Danieli G; Dalmonte PR; Montroni M
    Minerva Med; 1970 Jul; 61(55):3032-9. PubMed ID: 4193544
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum immunoglobulin levels and histomorphological changes in the liver in chronic liver diseases].
    Dinkov L; Peeva D; Velev G; Etŭrska M; Donov M
    Vutr Boles; 1984; 23(4):31-7. PubMed ID: 6506658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
    Labò G; Barbara L; Gasbarrini G; Roda E; Schiavina M; Bonvicini F
    Minerva Med; 1972 Oct; 63(75):4055-9. PubMed ID: 4563998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.